Synthetic Biologics is a late-stage clinical company developing therapeutics designed to preserve the microbiome. The Company is developing an oral enzyme for the prevention of C. difficile infections, and a series of monoclonal antibody therapies for the treatment of Pertussis and Acinetobacter infections. In addition, it is developing a drug candidate for the treatment of relapsing-remitting multiple sclerosis and cognitive dysfunction in multiple sclerosis.
Type | Public | |
Founded | 2001 | |
HQ | Rockville, MD, US | Map |
Website | syntheticbiologics.com |
USD | |
---|---|
Net income (Q2, 2020) | (2.9m) |
EBIT (Q2, 2020) | (2.9m) |
Market capitalization (8-Feb-2021) | 74.2m |
Closing stock price (8-Feb-2021) | 1.2 |
Cash (30-Jun-2020) | 8.1m |
EV | 66.8m |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 355.6k | 293.4k | ||||||||||||||||||||||||||
General and administrative expense | 694.3k | 681.8k | 1.5m | 1.2m | 1.1m | 1.1m | 1.3m | 1.9m | 1.1m | 1.8m | 1.2m | 1.7m | 2.2m | 1.6m | 2.4m | 2.1m | 2.1m | 2.1m | 1.6m | 1.7m | 1.6m | 1.4m | 1.5m | 1.2m | 1.0m | 1.1m | 1.4m | 1.3m |
R&D expense | 279.6k | 289.0k | 386.0k | 547.0k | 763.0k | 1.1m | 1.2m | 1.5m | 2.7m | 2.8m | 3.7m | 6.5m | 7.5m | 10.0m | 8.2m | 7.2m | 7.1m | 6.1m | 4.8m | 4.1m | 3.4m | 3.6m | 2.8m | 2.4m | 2.6m | 4.1m | 1.6m | 1.6m |
Operating expense total | 973.9k | 970.8k | 1.9m | 1.7m | 1.8m | 2.2m | 2.5m | 3.4m | 3.8m | 4.7m | 4.9m | 8.2m | 9.7m | 11.7m | 10.6m | 9.3m | 9.2m | 8.1m | 6.5m | 5.8m | 5.0m | 5.0m | 4.3m | 3.6m | 3.6m | 5.2m | 3.0m | 2.9m |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 8.4m | 4.6m | 6.8m | 5.9m | 4.5m | 7.6m | 6.9m | 5.1m | 11.2m | 7.8m | 3.3m | 12.0m | 4.8m | 31.8m | 15.1m | 10.0m | 4.5m | 13.5m | 13.4m | 21.1m | 11.0m | 7.1m | 9.5m | 24.7m | 21.7m | 18.7m | 10.1m | 8.1m |
Accounts Receivable | 444.7k | 494.9k | 440.0k | 245.0k | 122.0k | |||||||||||||||||||||||
Prepaid Expenses | 75.5k | 123.8k | 83.0k | 94.0k | 151.0k | 2.2m | 1.9m | 1.6m | 1.3m | 1.4m | 1.4m | 1.6m | 7.0m | 10.3m | 7.1m | 5.8m | 3.1m | 3.4m | 1.5m | 1.3m | 606.0k | 535.0k | 559.0k | 860.0k | 1.3m | 1.2m | 1.1m | 897.0k |
Current Assets | 8.9m | 8.1m | 7.3m | 6.3m | 4.9m | 11.5m | 9.5m | 6.8m | 12.5m | 9.2m | 4.7m | 13.6m | 11.7m | 42.1m | 22.2m | 15.8m | 7.6m | 16.8m | 14.9m | 22.3m | 11.6m | 7.7m | 10.1m | 25.6m | 23.0m | 19.8m | 11.2m | 9.0m |
USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|
Net Income | (8.1m) | (17.1m) | (12.3m) | (19.8m) | (44.8m) | (27.8m) | (15.5m) | (13.4m) | (15.4m) |
Depreciation and Amortization | 144.0k | 63.0k | 43.0k | 20.0k | 72.0k | 157.0k | 245.0k | 272.0k | 240.0k |
Accounts Payable | 153.0k | 7.0k | (253.0k) | 854.0k | 3.4m | (2.4m) | 27.0k | (987.0k) | 1.3m |
Cash From Operating Activities | (2.9m) | (8.9m) | (7.7m) | (16.1m) | (38.9m) | (27.9m) | (20.2m) | (17.3m) | (13.9m) |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (3.9m) | (5.0m) | (1.2m) | (3.1m) | (5.0m) | (2.2m) | (4.7m) | (8.1m) | (3.8m) | (8.4m) | (13.3m) | (12.4m) | (26.0m) | (33.5m) | (11.1m) | (16.8m) | (25.3m) | (3.1m) | (7.4m) | (18.3m) | (2.3m) | (6.5m) | (10.2m) | (3.5m) | (7.1m) | (12.2m) | (3.0m) | (5.9m) |
Depreciation and Amortization | 108.1k | 132.8k | 20.0k | 39.0k | 51.0k | 11.0k | 23.0k | 33.0k | 3.0k | 7.0k | 13.0k | 8.0k | 19.0k | 39.0k | 37.0k | 57.0k | 111.0k | 57.0k | 116.0k | 172.0k | 71.0k | 141.0k | 207.0k | 62.0k | 122.0k | 182.0k | 58.0k | 116.0k |
Accounts Payable | 54.1k | (39.7k) | (72.0k) | (110.0k) | 2.0k | (199.0k) | (182.0k) | 189.0k | 631.0k | 937.0k | 731.0k | 563.0k | 7.7m | 5.0m | 184.0k | 143.0k | (171.0k) | 1.8m | (270.0k) | (895.0k) | (527.0k) | (803.0k) | (1.1m) | (267.0k) | 490.0k | 1.4m | (1.1m) | (1.3m) |
Cash From Operating Activities | (1.2m) | (2.1m) | (1.4m) | (2.7m) | (4.1m) | (1.7m) | (3.3m) | (5.0m) | (3.5m) | (6.8m) | (11.3m) | (5.5m) | (12.7m) | (27.9m) | (5.7m) | (11.5m) | (17.5m) | (6.0m) | (11.7m) | (16.3m) | (6.1m) | (10.4m) | (14.0m) | (4.2m) | (7.2m) | (10.3m) | (5.0m) | (7.0m) |
USD | Q2, 2011 |
---|---|
Financial Leverage | 1 x |
Synthetic Biologics has 1.34k Twitter Followers. The number of followers has increased 2.1% month over month and increased 3.5% quarter over quarter
When was Synthetic Biologics founded?
Synthetic Biologics was founded in 2001.
Who are Synthetic Biologics key executives?
Synthetic Biologics's key executives are Steven Shallcross, Jeffrey J. Kraws and Michael Kaleko.
How many employees does Synthetic Biologics have?
Synthetic Biologics has 11 employees.
Who are Synthetic Biologics competitors?
Competitors of Synthetic Biologics include TG Therapeutics, AcelRx Pharmaceuticals and Neurocrine Biosciences.
Where is Synthetic Biologics headquarters?
Synthetic Biologics headquarters is located at 9605 Medical Center Dr #270, Rockville.
Where are Synthetic Biologics offices?
Synthetic Biologics has an office in Rockville.
How many offices does Synthetic Biologics have?
Synthetic Biologics has 1 office.
Receive alerts for 300+ data fields across thousands of companies